PER 1.27% 8.0¢ percheron therapeutics limited

EQUITY RESEARCH REPORT - WILSON dated 18 Jan 2022, page-5

  1. 3,268 Posts.
    lightbulb Created with Sketch. 287
    Everything on words is good but meantime there has been the J.P. Morgan conference in San Francisco one (if not the) of the most important conference in the bio/pharma world and no sign or whatsoever from the management of Antisense ANP the company that supposedly will OWN the DMD SPACE as loud and clearly said on the last AGM.
    I am speechless and incredulous to such “unexpected” oversight
    Last edited by imperatore: 18/01/22
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.